mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.005 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.006 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.01 |